Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03502941 · ClinicalTrials.gov registry record · NA
Effect of an EAA/Whey Composition on Protein Metabolism
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03502941 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 16 participants.
The verdict
NCT03502941, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Sarcopenia, a progressive loss of muscle mass, strength and function, is an inevitable natural process of aging. While it may be impossible to completely reverse the progress of sarcopenia, it is well established that intake of dietary protein through essential amino acids (EAAs) and whey protein increases anabolic response. The current study will test if a specially formulated mixture of EAAs and whey protein can maximally stimulate anabolic responses at the levels of whole body and muscle compared to whey protein alone.
Interventions
- DIETARY_SUPPLEMENT 6.3 g of EAAs mixture and whey protein isolate
- DIETARY_SUPPLEMENT 12.6 g of EAAs mixture and whey protein isolate
- DIETARY_SUPPLEMENT 12.6 g of whey protein isolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-06-20 |
| Est. Completion | 2019-07-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03502941
The ClinicalTrials.gov registry entry for NCT03502941 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 6.3 g of EAAs mixture and whey protein isolate is the first listed.
NCT03502941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03502941 about?
NCT03502941 is a clinical study titled "Effect of an EAA/Whey Composition on Protein Metabolism". Sarcopenia, a progressive loss of muscle mass, strength and function, is an inevitable natural process of aging. While it may be impossible to completely reverse the progress of sarcopenia, it is well established that intake of dietary protein through essential amino acids (EAAs) and whey protein in...
What is the current status of trial NCT03502941?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2018-06-20. Estimated completion is 2019-07-17.
What interventions are being tested in trial NCT03502941?
The interventions under investigation include: 6.3 g of EAAs mixture and whey protein isolate (DIETARY_SUPPLEMENT), 12.6 g of EAAs mixture and whey protein isolate (DIETARY_SUPPLEMENT), 12.6 g of whey protein isolate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03502941?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.